A B S T R A C T Lymphocyte subsets were assessed in patients with measles using the OKT range of monoclonal antibodies. A significant decrease in cells reacting with the OKT3 and OKT4 monoclonal antibodies was observed. When the tests were repeated 3 wk after the acute infection, significant recovery of these subsets was observed. The abnormality in lymphocyte subsets could be reproduced by treating normal lymphocytes with measles virus in vitro. When lymphocytes from patients with measles or when normal cells infected with measles virus in vitro were treated with either levamisole or L-ascorbic acid for 15 min and then retested with the OKT antisera, restoration of the previously depleted OKT3' and OKT4+ cell population was observed. Ascorbic-acid treatment also, to a certain extent, reversed the inability of measles mononuclear cells to produce lymphocyte mitogenic factor (helper factor for B cells) after pokeweed mitogen activation. This abnormality, however, could not be reversed by in vitro treatment with levamisole. Measles patients treated with L-ascorbic acid demonstrated no accelerated recovery in either their lymphocyte subset profile or their ability to produce lymphocyte mitogenic factor. Although the cause of the depressed OKT3' and OKT4+ lymphocyte subpopulations in patients with measles is not clear, the results suggest that the effect is not due to an aberration of protein synthesis, but rather to a blocking or steric change produced by the virus on the cell membrane. It is likely that both ascorbic acid and levamisole have the ability to reverse this effect by virtue of their antioxidant properties.
INTRODUCTION
There has been widespread interest in the effects of measles virus infection on immune function because of the long-recognized depression of cell-mediated immune responses that accompanies infection with this virus (1) . Since measles virus has been repeatedly detected in circulating blood lymphocytes (2) and has been recovered from lymphocytes stimulated by phytohemagglutinin (PHA)' in vitro (3) , it has been inferred that measles affects immune responses by infecting certain lymphocyte subpopulations. Measles virus replicates equally well in all major human mononuclear (MN) cell subpopulations, including T and B lymphocytes and monocytes (4) . Furthermore, the virus can productively infect both T cells with IgG (T(,) or IgM (TM) receptors on their surface membranes (5) . It has been previously shown, however, that it is primarily helper-cell function that is defective in measles infection (6, 7) and the finding of infective virus in all subpopulations does not necessarily imply defective function of all those subpopulations.
Monoclonal antibodies directed against specific human subsets provide a tool for the analysis of T cell subpopulations in man (8) . In particular, the OKT3 antiserum defines the entire peripheral T cell population, the OKT4 antiserum defines 55-60% of human T cells of the so-called inducer/helper subset, whereas the OKT8 antiserum is directed against suppressor/ cytotoxic T cells (9) . This study investigated lymphocyte subsets in patients with acute measles infection and indicated depression of total T cells as shown by reactivity with the OKT3 antibody and by E rosettes. The OKT4+ subset was particularly involved. Because the antihelminthic drug levamisole (LMS) has been described as having immunostimulatory activities (10. 11) , its effect on these abnormal lymphocyte suibsets was assessed in vitro. The results indicated that LMS produced a rapid and remarkable increase in the OKT.3 and OKT4+ lymphocyte subsets. To observe whether this response was specific to LMS, the effect of ascorbic acid, another antioxidant agent, was similarly assessed and it too produced restoration of cell membrane markers. In vivo use of high doses of ascorbic acid, however, did not reverse the abnormality of lymphocyte subsets in patients with measles infection. Because the finding of abnormal lymphocyte subsets does not always correlate with functional lymphocyte activity, the produiction of a T cell-derived helper factor (lymphocyte mitogenic factor [LMF] ) by measlesinfected cells was assessed before and after treatment with the antioxidant drugs.
METHODS
Patients. Studies werre carried otit on 42 well-nourished African children ranging in age from 4 mo to 5 yr (the majority being 1.5 to 3 yr old). All children had uncomplicated measles, as assessed by clinical investigation. roentgenogram, and absence of pyrexia after the rash had reached its maximum intensity. C(hildren were treated with only a mild analgesic (paracetemol) although some received 250 mg vitamin C/d (Propan Laboratories. Johannesburg, South Africa). Tests were performed in the acute phase of the disease, usually on the day of the appearance of the rash or I d thereafter. Normal adult laboratory workers served as daily controls. In previouis stuidies from this laboratory (unpublished data), it has been shown that T cell subsets are similar in distribution in adults and children.
Preparation of peripheral blood (MN cells Analysis of lymphocyte subpopulations by means of monoclonal antibodies. Production and characterization of monoclonal antibodies OKT3. OKT4, and OKT8 were subjects of prior reports (9, 12) . Since these antibodies were of the IgG2 subclass and fixed complement. they were used for complement-mediated lysis. Phagocyte-depleted MN cells (1.0 X 106) wvere treated with 5 ql of the different reconstittited monoclonal antibodies (Orthoclone. Ortho Pharmaceutical, Raritan, NJ) at room temperature for 45 mim. Stubsequently, cells were incubated with a 1:5 dilution of fresh rabbit complement for 1 h at 37°C. Background cytotoxicity was determined with MN cells incubated with rabbit complement alone, and spontaneous cell death was in the range of 0 to 2% of cells. Cell death after incubation with antibody and complement was determined by trypan blue staining and was expressed as a percentage of OKT3+, OKT4+, and OKT8+ cells. In some experiments, lymphocyte subsets were assessed with an indirect immunofluorescence technique (12) and were enumerated under a Leitz fluorescence microscope (E. Leitz, Inc., Rockleigh, NJ).
Enumeration of various types of MN cells. Macrophages, B lymphocytes, T lymphocytes, and null cells were determined with the Quantigen T and B cell assay kit (Bio-Rad Laboratories, Richmond, CA). Briefly, MN cells from Hypaque-Ficoll gradients are incubated with Immunobeads at 37°C for 1 h. Yellow-brown immunobeads possessing polyclonal anti-human antibodies bind to and rosette B cells. Colorless immunobeads possessing a monoclonal anti-T antibody (TIOI), which correlate with E rosette-positive lymphocytes, bind to and rosette T lymphocytes. Monocytes were identified by their ability to ingest both types of beads and the remaining unlabeled cells represented the null cell population.
Enumeration of E rosette-forming cells. E rosette-forming cells were quantitated by spontaneous rosette formation with sheep erythrocytes (SRBC). Briefly, 1 X 106 lymphocytes were placed in round-bottomed tubes and were incubated with an equial volume of 1% SRBC in the presence of 10% fetal calf serum (Gibco Laboratories) at 37°C for 15 min, centrifuged at 100 g for 5 min, and placed on ice for a minimum of 1 h. After gentle resuspension of the pelleted cells. the percentage of lymphocytes binding three or more SRBC was enumerated. In some experiments, E rosette results were confirmed with the OKTII antibody that is reactive with >95% of E rosette-positive cells.
In vitro effects of antioxidant agents on lymphocyte subsets, The effects of the following drugs vere assessed: L-2,3,5,6-tetra-hydro-6-phenylimidazothiazole (LMS) (Ethnor laboratories, Johannesburg, South Africa) and L.-ascorbic acid, (BDH Chemicals Ltd., Poole, England). These agents were dissolved in RPMI 1640 and added in varying concentrations to adherent cell-depleted MN cells at 37°C. At different time periods, cells were washed three times in HBSS and enumerated for cell surface receptors by the abovementioned techniques. In some experiments, cells were treated for 16 h with 10 yg/ml cycloheximide (Sigma Chemical Co., St. Louis, MO), after which they were washed and then exposed to the above pharmacological agents.
Production and assay of lIMF. MN to have an optimal effect), a significant increase in the number of OKT3+, OKT4+, and OKT8+ cells was observed. In most cases the trend was toward normalization of the ratio between OKT4+ and OKT8+ cells (Table IV) .
When cells from patients with acute measles were pulsed in vitro with 10-4 M L-ascorbic acid, considerable increase in the OKT3+ and OKT4+ cell populations was observed, with minimal improvement in the OKT8+ population. Once again, a significant normalization of the ratio between OKT4+ and OKT8+ cells was found (Table V) . Because the possibility existed that ascorbate might enhance the capacity of the measles-infected cells to antibody-and complementmediated lysis, these experiments were repeated using indirect fluorescence microscopy to assess subtypes before and after ascorbate treatment. As can be seen in Table VI (Table VII) . However, when measles MN cells were initially pulsed with L-ascorbic acid (10' M) for 2 h and then cultured for LMF production, a significant increase in the pro- showed a significant decrease in the OKT4+ population (P < 0.005). Some decrease in both the total OKT3' subset and the OKT8+ population was noted but these changes were not statistically significant (Fig. 1) . A maximal effect of the measles virus on the OKT4+ population could be detected after only 2 h of incubation with the virus, but cells treated with inactivated measles virus had no effect on the lymphocyte subsets. When MN cells that were infected with measles virus were then washed and pulsed with L-ascorbic acid for only 30 min (10-M), significant recovery of the OKT4 marker was detected (P < 0.005). Moderate increases in both the OKT3+ and OKT8+ subsets were also noted but these results were not statistically significant.
When enriched OKT4+ and OKT8+ populations were individually activated by PHA and then treated with live or inactivated measles virus, viral antigen as detected by membrane fluorescence was observed on both the OKT4-and OKT8-enriched cell populations that had been treated with live virus (Table VIII) .
DISCUSSION
In all patients examined in this study, we found the percentage of T cells to be depressed, using monoclonal OKT3 antibody and Quantigen beads, as well as enumerating E rosette-forming cells. In many, but not all patients, an absolute lymphopenia was present. The finding that patients with measles have depressed numbers of circulating T cells, has been shown by others (13, 14) and it has been suggested that the virus may inactivate a population of helper T cells. T T LIVE FIGURE 1 The effect of adding inactivated measles virus, measles virus alone, or measles virus followed by L-ascorbate on lymphocyte subsets. All lymphocytes were pretreated with PHA for 48 h before addition of measles virus.
Farland (7) showed that a defect of helper T cells existed in measles-infected mice, and in other studies the virus has been shown to suppress antibody synthesis when added during the first 48 h of lymphocyte culture (15) . Furthermore, MN cells from a group of patients with acute measles infection were shown to develop less intracytoplasmic immunoglobulin after stimulation with PWM than controls, owing primarily to a defect in helper factor (LMF) production (6) . Al- though it has been proposed that binding of measles virus to T cells may alter the circulating lymphocyte subpopulations (16) (20) and LMS (21) have been shown to increase intracellular cyclic guanosine nmonophosphate levels, but it would be speculative to suggest that this effect restores antigenic determinants on infected cells, especially after so short a period of exposure to the drugs. A further possible mechanism of action of ascorbate and LMS is a direct antiviral effect. However, although ascorbate has been shown to inactivate a variety of enteroviruses (22) , there is little evidence that it or LMS has a direct effect on paramyxoviruses.
The finding that measles-infected lymphocytes, treated with ascorbic acid recovered their OKT4 an-978 tigens, suggested that the drug may have the same effect when given to patients during the acute phase of their illness. Untreated children retained abnormal lymphocyte markers 1 wk after the acute infection, but by 3 wk, some recovery was evident. Similar findings were evident in the treated group and ascorbate did not accelerate the recovery of the subset markers. In fact, recovery at 3 wk was less in the ascorbatetreated group than in the nontreated group. It is not known, however, whether the dose administered was adequate to reverse the abnormal subset markers in vivo.
Recently, considerable evidence has appeared to indicate that defects in lymphocyte subsets do not necessarily correlate with defective in vitro functional assays of help or suppression (23, 24) . In this study, although lymphocyte subset markers had not recovered 1 wk after the acute episode, the production of LMF, which was initially depressed, improved considerably after 1 wk. This might suggest that the effect of virus on surface protein antigens and on helper cell function occurs by different mechanisms. When MN cells from measles patients in the acute stage of their illness were pulsed with LMS before culture for LMF production, no improvement in LMF production could be detected. The number of samples tested, however, was limited. It is noteworthy that treatment of measles MN cells with LMS resulted in a significant increase not only in the OKT4+ population, but also in the OKT8+ population. This could explain the lack of effect of LMS on the ability of cells to produce LMF. It also suggests that this agent has a highly nonspecific action on cell membranes. When measles MN cells were pulsed with ascorbate, significant improvement in LMF production was observed, and it has previously been shown that lymphocyte function that was depressed by in vitro exposure to influenza virus could be counteracted by ascorbic acid treatment (25) .
In the present study, the complexity of measles virus infection on human lymphocytes was demonstrated. Not only does the virus inhibit the production of LMF and other lymphokines (17) , but in addition it causes an aberration in lymphocyte subset profile, resulting in low OKT3+, OKT4+, and OKT1I+ cell populations. The exact mechanism of ascorbic acid activity in reversing both the defective LMF production and the abnormal subset profile is not clear, but these findings reiterate the complexity of viral interaction with cells of the immune system. We are unable to explain the disparity between LMS and ascorbate effects on LMF production, as both these compounds had a similar effect on lymphocyte subset markers and neither influenced the number of E rosette-forming cells. It is possible, therefore, that although these two agents have some effects in common, they may also be acting by different mechanisms, especially concerning helper factor production. As regards possible benefit of these drugs, it appears as though children treated with ascorbate from their time of admission to hospital demonstrated no obvious clinical benefit from this therapy.
